APOE and triple-A syndrome: In the present study, treatment with gasdermin inhibitor disulfiram reduced aneurysmal aortic diameter enlargement, lowered AAA incidence, and ameliorated aneurysm severity in ApoE deficient mice following Ang II infusion.